# Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

> **NCT00136084** · PHASE3 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 238 (actual)

## Conditions studied

- Leukemia, Myelocytic, Acute

## Interventions

- **DRUG:** Cladribine, Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone
- **DRUG:** Etoposide, Cytarabine, Gemtuzumab, L-asparaginase, Mercaptopurine, methotrexate, Mitoxantrone, Prednisone, Vincristine

## Key facts

- **NCT ID:** NCT00136084
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2008-07
- **Final completion:** 2012-06
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2012-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00136084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00136084, "Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00136084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*